2CJ-17577-29917
2 vaccinations
3 coded responses
11 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 601 / IL
- Registered
- 2021-12-09
- Relationship
- Child or adolescent in my care
- Guardian
- BXB-20762-66580
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-18
Dose 1 — Pfizer-BioNTech
-
2021-12-09
Registered in v-safe
-
2021-12-09
Dose 2 — Pfizer-BioNTech
-
2021-12-10
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-12
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-12-15
-
2021-12-18
Survey response — day 7, dose 2, dependentMedDRA: Nasal congestion, Rhinorrhoea — Feeling: FairFree text: Stuffy, runny noseMedDRA releases: 2024-11 · check-in free text available
- 2021-12-23
- 2021-12-31
-
2022-01-06
Survey response — day 28, dose 2, dependentMedDRA: Chest pain, Laryngitis, Oropharyngeal pain — Feeling: Poor · Be unable to work or attend schoolFree text: Sore throat, chest pain, laryngitisMedDRA releases: 2024-11 · check-in free text available
- 2022-01-14
- 2022-01-23
- 2022-03-10
-
2022-06-09
Survey response — 6 months, dose 2, dependentMedDRA: Epilepsy, Seizure — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: March 5, 2022. She had afebrile seizure and has since been diagnosed with epilepsyMedDRA releases: 2024-11 · check-in free text available
-
2022-06-09
Report sent to call center — 6 months, dose 2, dependentGet care from a doctor or other healthcare professionalEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-06-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-18 | Pfizer-BioNTech | No |
| 2 | 2021-12-09 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — day 7, dose 2, dependent
Systemic reaction (other): Stuffy, runny nose
Release 10 — day 28, dose 2, dependent
Symptoms: Sore throat, chest pain, laryngitis
Release 12 — 6 months, dose 2, dependent
Symptoms: March 5, 2022. She had afebrile seizure and has since been diagnosed with epilepsy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest pain | · | · | ✓ |
| SD | Epilepsy | · | · | ✓ |
| SD | Laryngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Seizure | · | · | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release